Perhaps consistent with a protective role of lower TMEM106B levels, increased levels of TMEM106B mRNA and protein have been observed in brains from FTD-TDP patients, both with and without GRN mutations [10, 20, 21]. This evidence concerns the gene TMEM106B and frontotemporal dementia.